Skip to main content
. 2023 Feb 11;61(1):427–436. doi: 10.1080/13880209.2023.2174145

Figure 2.

Figure 2.

Sanziguben polysaccharides (SZP) improved gut microbiota in diabetic nephropathy (DN) mice. (A) Shannon index curve. The alpha diversity of the gut microbiome: (B) ACE index, (C) Chao index, (D) Shannon index and (E) Simpson index. (F) Unweighted UniFrac PCoA (principal coordinates analysis). (G) Relative abundance of intestinal microbiota at the phylum level, (H) Proteobacteria and (I) Verrucomicrobiota. (J)Abundance changes in representative bacteria at the genus level are shown in a heatmap. Genera that were statistically different with SZP treatment: the relative abundance of (K) Akkermansia, (L) Klebsiella, (M) Marvinbryantia, (N) Blautia, (O) Escherichia-Shigella and (P) Eubacterium_xylanophilum_group. All data were expressed as the mean ± SD (n = 6). #p< 0.05, ##p< 0.01, ###p< 0.001 vs. NC group; *p< 0.05, **p< 0.01 vs. DN group.